Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis
Mar Guasp, Eloi Giné-Servén, Estibaliz Maudes, et al.
Neurology (2021) Vol. 97, Iss. 1
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Autoimmune Encephalitis Misdiagnosis in Adults
Eoin P. Flanagan, Michael D. Geschwind, A. Sebastian López‐Chiriboga, et al.
JAMA Neurology (2022) Vol. 80, Iss. 1, pp. 30-30
Open Access | Times Cited: 162
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease
Josep Dalmau, Francesc Graus
The Lancet Neurology (2023) Vol. 22, Iss. 6, pp. 529-540
Closed Access | Times Cited: 76
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
Mar Guasp, Mireia Rosa-Justícia, Amaia Muñoz‐Lopetegi, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 10, pp. 899-910
Closed Access | Times Cited: 55
Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis
Mar Guasp, L. Aguilar, Lídia Sabater, et al.
Neurology (2022) Vol. 98, Iss. 14
Closed Access | Times Cited: 41
Spectrum of Novel Anti–Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders
Dominique Endres, Katharina von Zedtwitz, Isabelle Matteit, et al.
Biological Psychiatry (2022) Vol. 92, Iss. 4, pp. 261-274
Closed Access | Times Cited: 32
Autoimmune encephalitis: recent clinical and biological advances
James Varley, Christine Strippel, Adam E. Handel, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 4118-4131
Open Access | Times Cited: 20
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults
Christopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2024) Vol. 51, Iss. 6, pp. 734-754
Open Access | Times Cited: 7
Autoimmune Encephalitis—Misdiagnosis, Misconceptions, and How to Avoid Them
Josep Dalmau, Francesc Graus
JAMA Neurology (2022) Vol. 80, Iss. 1, pp. 12-12
Closed Access | Times Cited: 25
Autoimmune Encephalitis
Mar Guasp, Josep Dalmau
Medical Clinics of North America (2025) Vol. 109, Iss. 2, pp. 443-461
Closed Access
The Neuropsychiatric Checklist for Autoimmune Psychosis: A Narrative Review
Ludger Tebartz van Elst, Kimon Runge, Philipp T. Meyer, et al.
Biological Psychiatry (2025)
Open Access
Bioenergetic markers in cerebrospinal fluid in first-episode psychosis: Are they predictors of early antipsychotic response and 1-year outcomes?
Eloi Giné-Servén, Ester Boix-Quintana, Alejandro Ballesteros, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111336-111336
Closed Access
Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
Jakob Theorell, Melanie Ramberger, Ruby Harrison, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study
Eloi Giné-Servén, M.J. Martínez-Ramírez, Ester Boix-Quintana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 112, pp. 110424-110424
Open Access | Times Cited: 23
Changing landscape in the field of paraneoplastic neurology: Personal perspectives over a 35-year career
Josep Dalmau
Handbook of clinical neurology (2024), pp. 11-32
Closed Access | Times Cited: 3
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis
Mattia Campana, Vladislav Yakimov, Joanna Moussiopoulou, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 353-362
Open Access | Times Cited: 3
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls
Rose Jeppesen, Anna Christine Nilsson, Nina Vindegaard Sørensen, et al.
Schizophrenia Research (2023) Vol. 252, pp. 39-45
Open Access | Times Cited: 7
The Importance of Cerebrospinal Fluid Investigation in First-episode Psychosis
Denis Pavǎl, Nicoleta Gherghel, Octavia Căpățînă, et al.
The Yale Journal of Biology and Medicine (2023) Vol. 96, Iss. 1, pp. 125-126
Open Access | Times Cited: 7
Blood and CSF anti-neuronal antibodies testing in psychotic syndromes: a retrospective analysis from a tertiary psychiatric hospital
Joana Lopes, Maria João Malaquias, Joana Freitas, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 626-635
Closed Access | Times Cited: 2
Psychosis and Schizophrenia
Carol S. Lim, Shreedhar Paudel, Daphne J. Holt, et al.
Elsevier eBooks (2024), pp. 305-320
Closed Access | Times Cited: 2
An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
Mikaela Syk, Emma Tornvind, Maike Gallwitz, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case–control comparison with patients testing negative
Jurjen J. Luykx, R.D. Visscher, Inge Winter-van Rossum, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 10, pp. 828-838
Closed Access | Times Cited: 2
Autoimmune Encephalitis With Psychotic Manifestations and Cognitive Impairment Presenting as Schizophrenia: Case Report and Literature Review
Yuanyuan Luo, Jieying Li, Fugui Jiang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Searching for Neuronal Antibodies in Psychiatric Diseases
Mar Guasp, Josep Dalmau
Neurology (2023) Vol. 101, Iss. 15, pp. 656-660
Open Access | Times Cited: 6
Cities and mental health

Frontiers research topics (2023)
Open Access | Times Cited: 5
Clinical presentations and treatment outcomes of Hashimoto encephalopathy at Siriraj Hospital – Thailand’s largest national tertiary referral center
Chaisak Dumrikarnlert, Smathorn Thakolwiboon, Vorapun Senanarong
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top